NEW YORK – EverlyWell has added PerkinElmer to its network of laboratory providers, the companies announced today.
The first tests to be made available through the collaboration will be for Lyme disease and food sensitivity, leveraging Waltham, Massachusetts-based PerkinElmer's expertise. Both tests use dried blood spot testing and were developed by PerkinElmer Genomics. The partners also will work to expand Austin, Texas-based EverlyWell's test menu.
Additional terms of the deal were not disclosed.